+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

From
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 70 Pages
  • Global
From
Severe Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Severe Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 1218 Pages
  • Global
From
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • August 2025
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
From
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
From
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more